Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Henlius Forecasts Profit in 1H 2023
2023-07-03 17:49
Zymedi announced their collaboration with the National Heart, Lung, and Blood Institute through a CTA CRADA to develop ZMA001 mAb, a potential treatment for Pulmonary Arterial Hypertension (PAH), a rare, female predominant disease
2023-07-03 08:00
Chime Biologics Announces Strategic Cooperation with Leads Biolabs and BeiGene to Advance LBL-007 mAb Development and Manufacturing Globally
2023-06-30 20:15
Harbour BioMed Announces Biologics License Application Acceptance of Batoclimab for Treatment of Generalized Myasthenia Gravis by NMPA
2023-06-29 21:26
Jowell Global Ltd. Granted Extension to Meet Nasdaq Minimum Bid Price Requirement
2023-06-29 20:00
HaemaLogiX Announces Positive Final Results from KappaMab Combination Phase IIb Myeloma Trial
2023-06-29 19:00
Jacobio Pharma Presents Clinical Results of Glecirasib in Colorectal Cancer
2023-06-29 16:31
Clarity establishes a US Center of Excellence for Targeted Copper Theranostics
2023-06-28 20:58
Flat Medical Expands Leadership Team to Manage Growth in Europe and the United States
2023-06-28 20:30
Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development
2023-06-28 20:00
Caliway Announces Positive Data from CBL-0201EFP Phase 2-Stage 1 Study of CBL-514 in Treating Moderate to Severe Cellulite
2023-06-28 18:30
Quhuo Creates a Warm and Supportive Work Environment for Deaf-Mute Riders
2023-06-28 18:00
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA
2023-06-28 09:57
LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma
2023-06-28 04:00
Momcozy Answers Challenges of Modern Motherhood with Thoughtfully Designed Products at Great Prices
2023-06-27 23:00
AI Diagnostic Platform Company Noul Releases 2022-2023 Sustainability Report
2023-06-27 21:00
EXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TEST
2023-06-27 19:00
Innovative paper-like, battery-free, AI-enabled sensor for holistic wound monitoring
2023-06-27 16:53
Momcozy Aims to Empower Breastfeeding Moms with Online Seminar After Successful FIME 2023 Exhibit
2023-06-27 10:00
Baird Medical, A Leading Developer and Provider of Microwave Ablation (MWA) Medical Devices in China, to be Publicly Listed on NASDAQ through a Proposed Business Combination with ExcelFin Acquisition Corp.
2023-06-26 21:54
1
77
78
79
80
81
801